NCT04085016View on ClinicalTrials.gov

Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

December 8, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2020

Conditions
Meibomian Gland DysfunctionMeibomitisDyslipidemias
Interventions
DEVICE

Keratograph 5M, Oculus, Wetzlar, Germany

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT04085016 - Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis | Biotech Hunter | Biotech Hunter